ARCHIVES

Afinitor Delayed Progression Compared To Tamoxifen Alone In Randomized Phase II Study

This article is from The Cancer Letter archive.

Vol. 33 No. 12 | December 31, 2010

Download PDF Visit The Full Archive

Related Articles

House and Senate Appropriators Pledge to Increase Biomedical Research Funding.

March 5, 1999

Interview With Screening Expert Barnett Kramer, PLCO Investigator

March 20, 2009

DCBDC Advisors Set aside $2 Mil. For Research On The Microenvironment of Breast Cancer

July 9, 1993

ASCO Releases Three Guidelines For Cancer Survivorship Care

April 25, 2014

Arizona Cancer Center Wins Core Grant Renewal

June 26, 2009

NCI-Approved Clinical Trials

April 26, 2002